Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Oregon Technology Today.
May 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |||
| 5 | 6 | 7 | 8 | 9 | 10 | 11 |
| 12 | 13 | 14 | 15 | 16 | 17 | 18 |
| 19 | 20 | 21 | 22 | 23 | 24 | 25 |
| 26 | 27 | 28 | 29 | 30 | 31 |
June 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | ||||||
| 2 | 3 | 4 | 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 | 13 | 14 | 15 |
| 16 | 17 | 18 | 19 | 20 | 21 | 22 |
| 23 | 24 | 25 | 26 | 27 | 28 | 29 |
| 30 |
July 2025
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | |
| 7 | 8 | 9 | 10 | 11 | 12 | 13 |
| 14 | 15 | 16 | 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 | 25 | 26 | 27 |
| 28 | 29 | 30 | 31 |
Press releases published on April 8, 2025
Oregon UAS Accelerator Opens Applications for Summer 2025 Cohort
EIN Presswire
·
April 8, 2025
Join the Oregon UAS Accelerator Summer 2025 Cohort! Access $165K+ in funding, mentorship, flight testing, and pitch live to investors. Apply now! PENDELTON, OR, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The Oregon UAS Accelerator, a premier …
Revolutionizing MEP Design: Tesla Outsourcing Services Drives Sustainability through Advanced BIM Solutions
EIN Presswire
·
April 8, 2025
Leveraging Cutting-Edge BIM Modeling and Clash Detection for Enhanced Project Efficiency and Seamless Facility Operation in the Age of Automation OR, UNITED STATES, April 8, 2025 /EINPresswire.com/ -- The Architecture, Engineering, and Construction (AEC …
First Patient Enrolled in NIH-Funded Expanded Access Program (EAP) Trial to Evaluate MN-166 in Amyotrophic Lateral Sclerosis (ALS) Patients
GlobeNewswire
·
April 8, 2025
LA JOLLA, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today announced enrollment of the …
Tevogen Bio CIO and Head of Tevogen.AI Presented at AI x Bio Philly Event Showcasing Philly’s Leading AI Biotechs
GlobeNewswire
·
April 8, 2025
WARREN, N.J., April 08, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), a healthcare company with dedicated efforts in immunotherapy and artificial intelligence, today announced that Mittul Mehta, Chief …
TransAlta to Host Annual Meeting of Shareholders and First Quarter 2025 Results Conference Call
GlobeNewswire
·
April 8, 2025
CALGARY, Alberta, April 08, 2025 (GLOBE NEWSWIRE) -- 2025 Annual Meeting of TransAlta Corporation Shareholders On Thursday, April 24, 2025, TransAlta Corporation (“TransAlta”) (TSX: TA) (NYSE: TAC) will hold its annual meeting of shareholders at 11:30 a.m. …
Zefiro Methane Corp. Appoints Correne Loeffler to its Board of Directors
GlobeNewswire
·
April 8, 2025
FORT LAUDERDALE, Fla., April 08, 2025 (GLOBE NEWSWIRE) -- ZEFIRO METHANE CORP. (Cboe Canada: ZEFI) (Frankfurt: Y6B) (OTCQB: ZEFIF) (the “Company”, “Zefiro”, or “ZEFI”) today announced the appointment of Correne Loeffler to the Company’s Board of Directors. …
NowVertical Group Wins 2025 Google Cloud Data & Analytics Partner of the Year for Latin America
GlobeNewswire
·
April 8, 2025
TORONTO, April 08, 2025 (GLOBE NEWSWIRE) -- NowVertical Group Inc. (TSXV: NOW) ("NowVertical" or the "Company"), a leading data and AI solutions provider, announced today that it has received the 2025 Google Cloud Data …
Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advanced Parkinson's Disease
GlobeNewswire
·
April 8, 2025
HUNTSVILLE, Ala., April 08, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, today announced the closing of a $ …
Myriad Genetics Announces Inducement Awards
GlobeNewswire
·
April 8, 2025
SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today that in connection with the hiring of Mr. Donnelly as chief commercial officer, …
Satellogic Awarded $30 Million Contract for Its AI-First Constellation Services
GlobeNewswire
·
April 8, 2025
NEW YORK, April 08, 2025 (GLOBE NEWSWIRE) -- Satellogic Inc. (NASDAQ: SATL), a leader in high-resolution Earth observation data, has been awarded a multi-year contract valued at $30 million to provide near-daily and ultra-low latency analytics from its …
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025
GlobeNewswire
·
April 8, 2025
PORTLAND, Maine, April 08, 2025 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the …
Artiva Biotherapeutics Appoints Subhashis Banerjee, M.D., as Chief Medical Officer
GlobeNewswire
·
April 8, 2025
SAN DIEGO, April 08, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases …
NeOnc Technologies Announces Near Completion of Phase I Enrollment for NEO212 Brain Cancer Therapy
GlobeNewswire
·
April 8, 2025
CALABASAS, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NASDAQ: NTHI), a clinical-stage biopharmaceutical company focused on innovative treatments for central nervous system (CNS) cancers and disorders, today announced that …
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities
GlobeNewswire
·
April 8, 2025
SAN MATEO, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) today announced that it has terminated the previously announced non-binding Letter of Intent (LOI) with Global Digital Holdings Inc., conducting business as QumulusAI …
Annexon Highlights Pivotal Data on First Potential Targeted Therapy for Guillain-Barré Syndrome (GBS) and Showcases New GBS Education Campaign at American Academy of Neurology (AAN) 2025 Annual Meeting
GlobeNewswire
·
April 8, 2025
Oral Presentation Features Phase 3 Data Showing Rapid Recovery and Durable Benefit of Tanruprubart (formerly ANX005) on Clinically Meaningful Measures across Multiple Stages of GBS Disease Education Campaign for Healthcare Providers called Move GBS Forward …
Nurix Therapeutics Reports First Quarter 2025 Financial Results and Provides a Corporate Update
GlobeNewswire
·
April 8, 2025
NX-5948 assigned the nonproprietary name “bexobrutideg” U.S. FDA Orphan Drug Designation granted to bexobrutideg for the treatment of Waldenström macroglobulinemia Achieved $7M in milestones and a $15M license extension fee from ongoing collaboration with …
Pythian Wins 2025 Google Cloud Databases Partner of the Year for North America
GlobeNewswire
·
April 8, 2025
LAS VEGAS, April 08, 2025 (GLOBE NEWSWIRE) -- Pythian Services Inc. (“Pythian”), a leading global services company specializing in data, analytics, and AI solutions, announced today that it has received the 2025 Google Cloud Databases Partner of the Year …
Fortinet Wins 2025 Google Cloud Technology Partner of the Year Award
GlobeNewswire
·
April 8, 2025
SUNNYVALE, Calif., April 08, 2025 (GLOBE NEWSWIRE) -- Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced it has won the 2025 Google Cloud Infrastructure Modernization Partner of the …
SADA Wins 2025 Google Cloud Global Partner of the Year Award for Google Workspace
GlobeNewswire
·
April 8, 2025
LAS VEGAS, April 08, 2025 (GLOBE NEWSWIRE) -- SADA, An Insight company, a leading business and technology consultancy and award-winning Google Cloud Premier level Partner across several product and engagement models, announced today it has received the …
BON Announces Unlocking Broccoli's Nutritional Power: Advanced Delivery System for Glucoraphanin Activation
GlobeNewswire
·
April 8, 2025
XI’AN, China, April 08, 2025 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or "the Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced our biotech innovation addresses …